Plinio Musetti - Raia Drogasil Director
| RADL3 Stock | BRL 24.78 0.32 1.27% |
Director
Mr. Plinio Villares Musetti serves as a Director of Raia Drogasil SA since November 10, 2011. He is Partner of Pragma responsible for equity investments. Before that, he worked at Grupo Villares, Elevadores Atlas Schindler, JP Morgan Partners and Satipel Industrial. He was also Chief Executive Officer of Elevadores Atlas. As Partner at JP Morgan Partners, he was responsible for private equity investments in Latin America. Since June 2010, he was Member of the Board of Raia SA and was appointed its Chairman in October 2010. He gained a degree in Business Administration from Universidade Presbiteriana Mackenzie, in Civil Engineering from Universidade Presbiteriana Mackenzie and in Management from Harvard Business School in 1989. since 2011.
| Age | 63 |
| Tenure | 13 years |
| Phone | 55 11 3769 5678 |
| Web | https://www.rd.com.br |
Raia Drogasil Management Efficiency
The company has return on total asset (ROA) of 0.0667 % which means that it generated a profit of $0.0667 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1825 %, meaning that it generated $0.1825 on every $100 dollars invested by stockholders. Raia Drogasil's management efficiency ratios could be used to measure how well Raia Drogasil manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Jairo Loureiro | Hypera SA | 77 | |
| Luciana Fleischner | Hypera SA | 43 | |
| Claudio Prado | Fleury SA | 55 | |
| Douglas Stange | WEG SA | 69 | |
| Ewaldo Russo | Fleury SA | 65 | |
| Thomas Herrmann | Lojas Renner SA | 67 | |
| Marcos Resende | Fleury SA | 49 | |
| Bernardo Hernandez | Hypera SA | 54 | |
| Lilian Guimaraes | Lojas Renner SA | 56 | |
| Luiz Carvalho | Fleury SA | 71 | |
| Maria Costa | Localiza Rent a | 58 | |
| Alvado Link | Hypera SA | 48 | |
| Dan Ioschpe | WEG SA | 53 | |
| Flavio Ferreira | Fleury SA | 51 | |
| Luca Mantegazza | Hypera SA | 42 | |
| Jose Araujo | Fleury SA | N/A | |
| Luiz Vaini | Fleury SA | 69 | |
| Esteban Fomperosa | Hypera SA | 70 | |
| David Coury | Hypera SA | 63 | |
| Flavia Almeida | Lojas Renner SA | 47 | |
| Alessandro Carlucci | Lojas Renner SA | 48 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0667 |
Raia Drogasil SA Leadership Team
Elected by the shareholders, the Raia Drogasil's board of directors comprises two types of representatives: Raia Drogasil inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Raia. The board's role is to monitor Raia Drogasil's management team and ensure that shareholders' interests are well served. Raia Drogasil's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Raia Drogasil's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carlos Dias, Director | ||
| Eugnio Zagottis, IR, Planning | ||
| Antonio Coelho, Chief Financial Officer, Member of the Executive Board | ||
| Renato Dias, Director | ||
| Marcelo Silva, Independent Director | ||
| Plinio Musetti, Director | ||
| Antonio Pipponzi, Chairman of the Board | ||
| Renato Raduan, Director of Retail Operations, Member of the Executive Board | ||
| Bruno Pipponzi, VP Board | ||
| Hector Nunez, Independent Director | ||
| Marclio Pousada, CEO Board | ||
| Marcilio Pousada, Chief Executive Officer, Member of the Executive Board | ||
| Ligia Mendes, Controllership charge | ||
| Jairo Loureiro, Independent Director | ||
| Cristiana Pipponzi, Director | ||
| Jose Rossetti, Independent Director | ||
| Fernando Varela, Chief Technology and Logistics Officer, Member of the Executive Board | ||
| Maria Souza, Director of Human Resources, Member of the Executive Board | ||
| Eugenio Zagottis, Investor Relations and Corporate Planning Officer, Member of the Executive Board | ||
| Antonio Freitas, Operations and Retail Director - Drogasil and Member of Executive Board | ||
| Gabriel Rozenberg, IR Director | ||
| Marco Bonomi, Independent Director | ||
| Paulo Galvao, Director | ||
| Marcello Zagottis, Chief Marketing, Sales and Commercial Officer, Member of the Executive Board |
Raia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Raia Drogasil a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0667 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 42.8 B | |||
| Shares Outstanding | 1.65 B | |||
| Shares Owned By Insiders | 27.26 % | |||
| Shares Owned By Institutions | 45.00 % | |||
| Price To Earning | 80.31 X | |||
| Price To Book | 7.48 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Raia Drogasil SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Raia Drogasil SA information on this page should be used as a complementary analysis to other Raia Drogasil's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Raia Stock analysis
When running Raia Drogasil's price analysis, check to measure Raia Drogasil's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raia Drogasil is operating at the current time. Most of Raia Drogasil's value examination focuses on studying past and present price action to predict the probability of Raia Drogasil's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raia Drogasil's price. Additionally, you may evaluate how the addition of Raia Drogasil to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |